［1］ LIM CJ,CECH TR.Shaping human telomeres:from shelterin and CST complexes to telomeric chromatin organization［J］.Nat Rev Mol Cell Biol,2021,22(4):283-298.
［2］ ARAMBURU T,PLUCINSKY S,SKORDALAKES E.POT1-TPP1 telomere length regulation and disease［J］.Comput Struct Biotechnol J,2020,18:1939-1946.
［3］ LUE NF.Duplex telomere-binding proteins in fungi with canonical telomere repeats:New lessons in the rapid evolution of telomere proteins［J］.Frontiers in Genetics,2021,12:638790.
［4］ JONES M,BISHT K,SAVAGE SA,et al.The shelterin complex and hematopoiesis［J］.The Journal of Clinical Investigation,2016,126(5):1621-1629.
［5］ SMITH EM,PENDLEBURY DF,NANDAKUMAR J.Structural biology of telomeres and telomerase［J］.Cell Mol Life Sci,2020,77(1):61-79.
［6］ BRAUN H,XU Z,CHANG F,et al.ZNF524 directly interacts with telomeric DNA and supports telomere integrity［J］.Nature Communications,2023,14(1):8252.
［7］ DENG Z,GLOUSKER G,MOLCZAN A,et al.Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome［J］.Proc Natl Acad Sci U S A,2013,110(36):E3408-E3416.
［8］ SHOEB M,MEIGHAN T,KODALI VK,et al.TERT-independent telomere elongation and shelterin dysregulation after pulmonary exposure to stainless-steel welding fume in-vivo［J］.Environmental Research,2024，250:118515.
［9］ KUMAR N,TANEJA A,GHOSH M,et al.Harmonin homology domain-mediated interaction of RTEL1 helicase with RPA and DNA provides insights into its recruitment to DNA repair sites［J］.Nucleic Acids Research,2024,52(3):1450-1470.
［10］ PALM W,DE LANGE T.How shelterin protects mammalian telomeres［J］.Annu Rev Genet,2008,42:301-334.
［11］ SOBINOFF AP,DI MARO S,LOW R,et al.Irreversible inhibition of TRF2(TRFH) recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells［J］.Cell Chem Biol,2023,30(12):1652-1665.
［12］ AMIR M,KHAN P,QUEEN A,et al.Structural features of nucleoprotein CST/Shelterin complex involved in the telomere maintenance and its association with disease mutations［J］.Cells,2020,9(2):359.
［13］ RAI R,BIJU K,SUN W,et al.Homology directed telomere clustering,ultrabright telomere formation and nuclear envelope rupture in cells lacking TRF2B and RAP1［J］.Nature Communications,2023,14(1):2144.
［14］ AKINCILAR SC,CHAN C,NG QF,et al.Non-canonical roles of canonical telomere binding proteins in cancers［J］.Cell Mol Life Sci,2021,78(9):4235-4257.
［15］ WOLF SE,HASTINGS WJ,YE Q,et al.Cross-tissue comparison of telomere length and quality metrics of DNA among individuals aged 8 to 70 years［J］.PLoS One,2024,19(2):e290918.
［16］ HAYFLICK L.The illusion of cell immortality［J］.Br J Cancer,2000,83(7):841-846.
［17］ DE BARDET JC,CARDENTEY CR,GONZALEZ BL,et al.Cell immortalization:In vivo molecular bases and in vitro techniques for obtention［J］.BioTech (Basel),2023,12(1):14.
［18］ HEAPHY CM,SUBHAWONG AP,HONG SM,et al.Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes［J］.Am J Pathol,2011,179(4):1608-1615.
［19］ AQUILANTI E,KAGELER L,WEN PY,et al.Telomerase as a therapeutic target in glioblastoma［J］.Neuro Oncol,2021,23(12):2004-2013.
［20］ YAN S,LIN S,QIU H,et al.Regulation of telomerase towards tumor therapy［J］.Cell Biosci,2023,13(1):228.
［21］ LIU M,ZHANG Y,JIAN Y,et al.The regulations of telomerase reverse transcriptase (TERT) in cancer［J］.Cell Death & Disease,2024,15(1):90.
［22］ WEN PY,WELLER M,LEE EQ,et al.Glioblastoma in adults:a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions［J］.Neuro Oncol,2020,22(8):1073-1113.
［23］ MA L,SHI Y,LI C,et al.MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas［J］.Front Immunol,2024,15:1323307.
［24］ REGMI M,WANG Y,LIU W,et al.From glioma gloom to immune bloom:unveiling novel immunotherapeutic paradigms-a review［J］.J Exp Clin Cancer Res,2024,43(1):47.
［25］ BRENNAN CW,VERHAAK RG,MCKENNA A,et al.The somatic genomic landscape of glioblastoma［J］.Cell,2013,155(2):462-477.
［26］ ALBERT NL,NELWAN DV,FLEISCHMANN DF,et al.Prognostic value of TSPO PET before radiotherapy in newly diagnosed IDH-wild-type glioblastoma［J］.J Nucl Med,2023,64(10):1519-1525.
［27］ DI NUNNO V,APRILE M,BARTOLINI S,et al.The biological and clinical role of the telomerase reverse transcriptase gene in glioblastoma:A potential therapeutic target［J］.Cells,2024,13(1):44.
［28］ OHBA S,KUWAHARA K,YAMADA S,et al.Correlation between IDH,ATRX,and TERT promoter mutations in glioma［J］.Brain Tumor Pathol,2020,37(2):33-40.
［29］ AQUILANTI E,KAGELER L,WATSON J,et al.Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume［J］.Neuro Oncol,2023,25(7):1275-1285.
［30］ WON SY,LEE JH,LEE N,et al.Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas［J］.PLoS One,2022,17(10):e276342.
［31］ EGLENEN-POLAT B,KOWASH RR,HUANG HC,et al.A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer［J］.Nat Commun,2024,15(1):672.
［32］ BENITES-ZAPATA VA,ULLOQUE-BADARACCO JR,ALARCON-BRAGA EA,et al.Telomerase activity and telomere length in women with breast cancer or without malignancy:A systematic review and meta-analysis［J］.Maturitas,2024,180:107882.
［33］ HASHIMOTO M,KURODA S,KANAYA N,et al.Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus［J］.Br J Cancer,2024,130(7):1187-1195.
［34］ AKINCILAR SC,UNAL B,TERGAONKAR V.Reactivation of telomerase in cancer［J］.Cell Mol Life Sci,2016,73(8):1659-1670.
［35］ HE Y,JIANG K,LIU B,et al.Spatiotemporal control of DNAzyme activity for fluorescent imaging of telomerase RNA in living cells［J］.Anal Chim Acta,2024,1287:342085.
［36］ PEREVALOVA AM,GULYAEVA LF,PUSTYLNYAK VO.Roles of interferon regulatory factor 1 in tumor progression and regression:Two sides of a coin［J］.Int J Mol Sci,2024,25(4):2153.
［37］ PALLINI R,SORRENTINO A,PIERCONTI F,et al.Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts［J］.Int J Cancer,2006,118(9):2158-2167.
［38］ FALCHETTI ML,FIORENZO P,MONGIARDI MP,et al.Telomerase inhibition impairs tumor growth in glioblastoma xenografts［J］.Neurol Res,2006,28(5):532-537.
［39］ WANG T,XUE Y,WANG M,et al.Silencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cells［J］.Oncol Rep,2012,28(4):1153-1158.
［40］ LAVANYA C,SIBIN MK,SRINIVAS BM,et al.RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells［J］.Cytotechnology,2016,68(6):2311-2321.
［41］ GE L,DENG Z,ZHANG Y,et al.Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells［J］.Oncol Rep,2011,26(6):1487-1495.
［42］ CHEN K,LI L,QU S,et al.Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R［J］.Aging (Albany NY),2020,12(24):25599-25613.
［43］ MAGGISANO V,CELANO M,LEPORE SM,et al.Human telomerase reverse transcriptase in papillary thyroid cancer:gene expression,effects of silencing and regulation by BET inhibitors in thyroid cancer cells［J］.Endocrine,2019,63(3):545-553.
［44］ ZHAO X,ZHANG C,LE Z,et al.Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor?related apoptosis?inducing ligand?induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo［J］.Int J Mol Med,2018，42(3):1283-1294.
［45］ MARIAN CO,CHO SK,MCELLIN BM,et al.The telomerase antagonist,imetelstat,efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth［J］.Clin Cancer Res,2010,16(1):154-163.
［46］ FERRANDON S,MALLEVAL C,EL HAMDANI B,et al.Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma［J］.Molecular Cancer,2015,14(1):134.
［47］ BRUEDIGAM C,PORTER AH,SONG A,et al.Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia［J］.Nat Cancer,2024,5(1):47-65.
［48］ BURCHETT KM,YAN Y,OUELLETTE MM.Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells［J］.PLoS One,2014,9(1):e85155.
［49］ ARSLAN DAVULCU E,OGUZ MB,KILIC E,et al.Treatment of anemia in myelofibrosis:focusing on novel therapeutic options［J］.Expert Opinion on Investigational Drugs,2024,33(1):11-27.
［50］ PLATZBECKER U,SANTINI V,FENAUX P,et al.Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge):a multinational,randomised,double-blind,placebo-controlled,phase 3 trial［J］.The Lancet (British Edition),2024,403(10423):249-260.
［51］ DIKMEN ZG,WRIGHT WE,SHAY JW,et al.Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells［J］.J Cell Biochem,2008,104(2):444-452.
［52］ CHIAPPORI AA,KOLEVSKA T,SPIGEL DR,et al.A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer［J］.Ann Oncol,2015,26(2):354-362.
［53］ WU X,ZHANG J,YANG S,et al.Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma［J］.Oncotarget,2017,8(8):13600-13619.
［54］ WANG X,HU CS,PETERSEN B,et al.Imetelstat,a telomerase inhibitor,is capable of depleting myelofibrosis stem and progenitor cells［J］.Blood Adv,2018,2(18):2378-2388.
［55］ JOSEPH I,TRESSLER R,BASSETT E,et al.The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines［J］.Cancer Res,2010,70(22):9494-9504.
［56］ BARWE SP,HUANG F,KOLB EA,et al.Imetelstat induces leukemia stem cell death in pediatric acute myeloid leukemia patient-derived xenografts［J］.Journal of Clinical Medicine,2022,11(7):1923.
［57］ JACKSON SR,ZHU CH,PAULSON V,et al.Antiadhesive effects of GRN163L-an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase［J］.Cancer Res,2007,67(3):1121-1129.
［58］ MENDER I,SENTURK S,OZGUNES N,et al.Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton［J］.Int J Oncol,2013,42(5):1709-1715.
［59］ FERRANDON S,MALLEVAL C,EL HB,et al.Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma［J］.Mol Cancer,2015,14:134.
［60］ GOLDBLATT EM,GENTRY ER,FOX MJ,et al.The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology,inhibits growth,and augments the effects of paclitaxel［J］.Mol Cancer Ther,2009,8(7):2027-2035.
［61］ KOZIEL JE,HERBERT BS.The telomerase inhibitor imetelstat alone,and in combination with trastuzumab,decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells［J］.Breast Cancer Res Treat,2015,149(3):607-618.
［62］ TAMAKAWA RA,FLEISIG HB,WONG JM.Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner［J］.Cancer Res,2010,70(21):8684-8694.
［63］ THOMPSON PA,DRISSI R,MUSCAL JA,et al.A phase I trial of imetelstat in children with refractory or recurrent solid tumors:a Children's Oncology Group Phase I Consortium Study (ADVL1112)［J］.Clin Cancer Res,2013,19(23):6578-6584.
［64］ MASCARENHAS J,KOMROKJI RS,PALANDRI F,et al.Randomized,single-blind,multicenter phase Ⅱ study of two doses of imetelstat in relapsed or refractory myelofibrosis［J］.J Clin Oncol,2021,39(26):2881-2892.
［65］ ZHOU J,LI T,GENG X,et al.Antisense oligonucleotide repress telomerase activity via manipulating alternative splicing or translation［J］.Biochem Biophys Res Commun,2021,582:118-124.
［66］ WANG F,CHENG Y,ZHANG C,et al.A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells［J］.J Neuro-Oncol,2019,143(1):57-68.
［67］ DIALA I,SHIOHAMA Y,FUJITA T,et al.Telomerase inhibition,telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT［J］.Nucleosides Nucleotides Nucleic Acids,2020,39(1-3):407-425.
［68］ KUBO T,ZHELEV Z,BAKALOVA R,et al.Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation［J］.Org Biomol Chem,2005,3(18):3257-3259.
［69］ LI Y,GU J,DING Y,et al.A small molecule compound Ⅸ inhibits telomere and attenuates oncogenesis of drug-resistant leukemia cells［J］.FASEB J,2020,34(7):8843-8857.
［70］ BRYAN C,RICE C,HOFFMAN H,et al.Structural basis of telomerase inhibition by the highly specific BIBR1532［J］.Structure,2015,23(10):1934-1942.
［71］ AL-KARMALAWY AA,MOUSA MHA,SHARAKY M,et al.Lead optimization of BIBR1591 to improve its telomerase inhibitory activity:Design and synthesis of novel four chemical series with in silico,in vitro,and in vivo preclinical assessments［J］.Journal of Medicinal Chemistry,2024,67(1):492-512.
［72］ HUSSAIN T,CHAI L,WANG Y,et al.Activation of PPAR-gamma prevents TERT-mediated pulmonary vascular remodeling in MCT-induced pulmonary hypertension［J］.Heliyon,2023,9(3):e14173.
［73］ POURBAGHERI-SIGAROODI A,BASHASH D,SAFAROGHLI-AZAR A,et al.Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line［J］.Eur J Pharmacol,2019,846:49-62.
［74］ DIZAJI AK,RAFAT A,MOVASSAGHPOUR AA,et al.The effect of telomerase inhibition on NK cell activity in acute myeloid leukemia［J］.Adv Pharm Bull,2023,13(1):170-175.
［75］ ZHANG Y,YANG X,ZHOU H,et al.BIBR1532 inhibits proliferation and enhances apoptosis in multiple myeloma cells by reducing telomerase activity［J］.PeerJ,2023,11:e16404.
［76］ LIN Z,WU Z,LUO W.Bulk and single-cell sequencing identified a prognostic model based on the macrophage and lipid metabolism related signatures for osteosarcoma patients［J］.Heliyon,2024,10(4):e26091.
［77］ GALA K,JAIN M,SHAH P,et al.Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment［J］.Life Sciences,2024,339:122416.
［78］ KONG W,LV N,WYSHAM WZ,et al.Knockdown of hTERT and treatment with BIBR1532 inhibit cell proliferation and invasion in endometrial cancer cells［J］.J Cancer,2015,6(12):1337-1345.
［79］ MAZLOUMI Z,RAFAT A,DIZAJI AK,et al.A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis［J］.Biochem Biophys Res Commun,2023,640:50-55.
［80］ GIUNCO S,ZANGROSSI M,DAL POZZOLO F,et al.Anti-proliferative and pro-apoptotic effects of short-term inhibition of telomerase in vivo and in human malignant B cells xenografted in zebrafish［J］.Cancers,2020,12(8):2052.
［81］ KUSOGLU A,GOKER BB,OZATES AN,et al.Telomerase inhibition regulates EMT mechanism in breast cancer stem cells［J］.Gene,2020,759:145001.
［82］ DOGAN F,OZATES NP,BAGCA BG,et al.Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells［J］.J Cell Biochem,2019,12(2):1282-1293.
［83］ WARD RJ,AUTEXIER C.Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment［J］.Mol Pharmacol,2005,68(3):779-786.
［84］ SHI Y,SUN L,CHEN G,et al.A combination of the telomerase inhibitor,BIBR1532,and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines［J］.Target Oncol,2015,10(4):565-573.
［85］ QIN H,GUO Y.Targeting telomerase enhances cytotoxicity of salinomycin in cancer cells［J］.ACS Omega,2022,7(34):30565-30570.
［86］ LIU Y,BETORI RC,PAGACZ J,et al.Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization［J］.Cell Chem Biol,2022,29(10):1517-1531.
［87］ BETORI RC,LIU Y,MISHRA RK,et al.Targeted covalent inhibition of telomerase［J］.ACS Chem Biol,2020,15(3):706-717.
［88］ UDROIU I,MARINACCIO J,SGURA A.Epigallocatechin-3-gallate induces telomere shortening and clastogenic damage in glioblastoma cel
ls［J］.Environ Mol Mutagen,2019,60(8):683-692.
［89］ SADAVA D,WHITLOCK E,KANE SE.The green tea polyphenol,epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells［J］.Biochem Biophys Res Commun,2007,360(1):233-237.
［90］ ADACHI S,NAGAO T,INGOLFSSON HI,et al.The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells［J］.Cancer Res,2007,67(13):6493-6501.
［91］ HIGDON JV,FREI B.Tea catechins and polyphenols:health effects,metabolism,and antioxidant functions［J］.Crit Rev Food Sci Nutr,2003,43(1):89-143.
［92］ KHAN N,AFAQ F,SALEEM M,et al.Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate［J］.Cancer Res,2006,66(5):2500-2505.
［93］ SHANKAR S,GANAPATHY S,HINGORANI SR,et al.EGCG inhibits growth,invasion,angiogenesis and metastasis of pancreatic cancer［J］.Front Biosci,2008,13:440-452.
［94］ SINGH BN,SHANKAR S,SRIVASTAVA RK.Green tea catechin,epigallocatechin-3-gallate (EGCG):mechanisms,perspectives and clinical applications［J］.Biochem Pharmacol,2011,82(12):1807-1821.
［95］ GURUNG RL,LIM HK,VENKATESAN S,et al.Targeting DNA-PKcs and telomerase in brain tumour cells［J］.Mol Cancer,2014,13:232.
［97］ AMERI Z,GHIASI S,FARSINEJAD A,et al.Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic,proliferative and inflammatory genes［J］.Life Sci,2019,228:66-71.
［97］ WAGHORN PA,JACKSON MR,GOUVERNEUR V,et al.Targeting telomerase with radiolabeled inhibitors［J］.Eur J Med Chem,2017,125:117-129.
［98］ LIU C,ZHOU H,SHENG XB,et al.Design,synthesis and SARs of novel telomerase inhibitors based on BIBR1532［J］.Bioorg Chem,2020,102:104077.
［99］ MACIEJEWSKA N,OLSZEWSKI M,JURASZ J,et al.Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres［J］.Cell Death Dis,2022,13(11):1005.
［100］ DOI T,SHIBATA K,YOSHIDA M,et al.(S)-stereoisomer of telomestatin as a potent G-quadruplex binder and telomerase inhibitor［J］.Org Biomol Chem,2011,9(2):387-393.
［101］ ZHANG L,TAMURA K,SHIN-YA K,et al.The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis［J］.Biochim Biophys Acta,2006,1763(1):39-44.
［102］ WANG S,YAN WW,HE M,et al.Aloe emodin inhibits telomerase activity in breast cancer cells:transcriptional and enzymological mechanism［J］.Pharmacol Rep,2020,72(5):1383-1396.
［103］ KONIECZNA N,ROMANIUK-DRAPALA A,LISIAK N,et al.Telomerase inhibitor TMPyP4 alters adhesion and migration of breast-cancer cells MCF7 and MDA-MB-231［J］.International Journal of Molecular Sciences,2019,20(11):2670.
［104］ LIU J,GUO L,YIN F,et al.Characterization and antitumor activity of triethylene tetramine,a novel telomerase inhibitor［J］.Biomed Pharmacother,2008,62(7):480-485.
［105］ CULLEN BR,GREENE WC.Regulatory pathways governing HIV-1 replication［J］.Cell,1989,58(3):423-426.
［106］ BATES PJ,LABER DA,MILLER DM,et al.Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer［J］.Exp Mol Pathol,2009,86(3):151-164.
［107］ ZHANG C,TANG S,WANG M,et al."Triple-Punch" strategy exosome-mimetic nanovesicles for triple negative breast cancer therapy［J］.ACS Nano,2024,18(17):5470-5482.
［108］ BAHREYNI A,MOHAMUD Y,ASHRAF NOUHEGAR S,et al.Synergistic viro-chemoimmunotherapy in breast cancer enabled by bioengineered immunostimulatory exosomes and dual-targeted coxsackievirus B3［J］.ACS Nano,2024,18(5):4241-4255.
［109］ ZHU J,PENG L,JEHAN S,et al.Activable photodynamic DNA probe with an "AND" logic gate for precision skin cancer therapy［J］.Research,2024,7:295.
［110］ LU Y,LIU S,LIANG J,et al.Self-propelled nanomotor for cancer precision combination therapy［J］.Advanced Healthcare Materials,2024,13(15):4212.
［111］ TANG J,WANG J,OU J,et al.A DNA/poly-(L-lysine) hydrogel with long shelf-time for 3D cell culture［J/OL］.Small Methods,2024［2024-01-17］.https://doi.org/10.1002/smtd202301236.
［112］ TONG X,GA L,AI J,et al.Progress in cancer drug delivery based on AS1411 oriented nanomaterials［J］.Journal of Nanobiotechnology,2022,20(1):57.
［113］ KHAN Y,AZAM T,SUNDAR JS,et al.Biophysical characterization of nucleolin domains crucial for interaction with telomeric and TERRA G-quadruplexes［J］.Biochemistry,2023,62(7):1249-1261.
［114］ TIEMANN J,LINDENKAMP C,WAGNER T,et al.The consideration of pseudoxanthoma elasticum as a progeria syndrome［J］.Front Biosci (Landmark Ed),2023,28(3):55.
［115］ JO J,BAE S,JEON J,et al.Bifunctional G-quadruplex aptamer targeting nucleolin and topoisomerase 1:Antiproliferative activity and synergistic effect of conjugated drugs［J］.Bioconjugate Chemistry,2023,34(1):238-247.
［116］ IRESON CR,KELLAND LR.Discovery and development of anticancer aptamers［J］.Molecular Cancer Therapeutics,2006,5(12):2957-2962.
［117］ ROSENBERG JE,BAMBURY RM,VAN ALLEN EM,et al.A phase Ⅱ trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma［J］.Investigational New Drugs,2013,32(1):178-187.
［118］ SOUNDARARAJAN S,CHEN W,SPICER EK,et al.The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells［J］.Cancer Res,2008,68(7):2358-2365.
［119］ GOLDSHMIT Y,TRANGLE SS,KLOOG Y,et al.Interfering with the interaction between ErbB1,nucleolin and Ras as a potential treatment for glioblastoma［J］.Oncotarget,2014,5(18):8602-8613.
［120］ LUO Z,YAN Z,JIN K,et al.Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates［J］.J Colloid Interface Sci,2017,490:783-796.
［121］ HE L,ZENG L,MAI X,et al.Nucleolin-targeted selenium nanocomposites with enhanced theranostic efficacy to antagonize glioblastoma［J］.J Mater Chem B,2017,5(16):3024-3034.
［122］ ALIBOLANDI M,ABNOUS K,RAMEZANI M,et al.Synthesis of AS1411-aptamer-conjugated CdTe quantum dots with high fluorescence strength for probe labeling tumor cells［J］.J Fluoresc,2014,24(5):1519-1529.
［123］ WU T,LIU Y,CAO Y,et al.Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma［J］.Adv Mater,2022,34(15):e2110364.
［124］ SATHIYASEELAN A,SARAVANAKUMAR K,MARIADOSS A,et al.pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment［J］.Carbohydr Polym,2021,262:117907.
［125］ WANG D,TIAN Y,ZHANG Y,et al.An assembly-inducing PDC enabling the efficient nuclear delivery of nucleic acid for cancer stem-like cell suppression［J］.Nanoscale,2022,14(41):15384-15392.
［126］ WANG W,WANG Y,MA M,et al.Drug-induced self-assembly cascade nanoreactor for synergistic tumor therapy［J］.ACS Appl Mater Interfaces,2022,14(39):44029-44038.
［127］ JIANG H,WANG LB,ZHANG YT,et al.An entropy-driven three-dimensional multipedal-DNA walker for ultrasensitive detection of cancer cells［J］.Anal Chim Acta,2022,1228:340299.
［128］ HOSSEINI NF,AMINI R,RAMEZANI M,et al.AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer［J］.Biomed Pharmacother,2022,155:113690.
［129］ MERAVIGLIA-CRIVELLI D,VILLANUEVA H,MENON AP,et al.A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression［J］.Mol Ther Nucleic Acids,2022,29:413-425.
［130］ ZENG S,SUN X,WAN X,et al.A cascade Fermat spiral microfluidic mixer chip for accurate detection and logic discrimination of cancer cells［J］.Analyst,2022,147(15):3424-3433.
［131］ YAN S,LIN S,CHEN K,et al.Natural product library screens identify sanguinarine chloride as a potent inhibitor of telomerase expression and activity［J］.Cells,2022,11(9):1485.
［132］ ZHU Z,TRAN H,MATHAHS MM,et al.Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity［J］.Pharmacol Res Perspect,2021,9(6):e882.
［133］ MURAKAMI J,NAGAI N,SHIGEMASA K,et al.Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines［J］.Eur J Cancer,1999,35(6):1027-1034.
［134］ GOMEZ DE,ARMANDO RG,ALONSO DF.AZT as a telomerase inhibitor［J］.Front Oncol,2012,2:113.
［135］ HAENDELER J,HOFFMANN J,RAHMAN S,et al.Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation［J］.FEBS Lett,2003,536(1-3):180-186.
［136］ WEI Z,QIN Q,CHEN J,et al.Oxoisoaporphine as potent telomerase inhibitor［J］.Molecules,2016,21(11):1534.
［137］ ARMANDO R,CABRERA M,VILARULLO R,et al.In vitro characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line［J］.Oncology Reports,2022,48(5):1.
［138］ CHUNG SS,ADEKOYA D,ENENMOH I,et al.Salinomycin abolished STAT3 and STAT1 interactions and reduced telomerase activity in colorectal cancer cells［J］.Anticancer Res,2017,37(2):445-453.
［139］ SHARMA V,KOUL N,JOSEPH C,et al.HDAC inhibitor,scriptaid,induces glioma cell apoptosis through JNK activation and inhibits telomerase activity［J］.J Cell Mol Med,2010,14(8):2151-2161.
［140］ WOO HJ,LEE SJ,CHOI BT,et al.Induction of apoptosis and inhibition of telomerase activity by trichostatin A,a histone deacetylase inhibitor,in human leukemic U937 cells［J］.Exp Mol Pathol,2007,82(1):77-84.
［141］ KHAW AK,SILASUDJANA M,BANERJEE B,et al.Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells［J］.Mutat Res,2007,625(1-2):134-144.
［142］ CHEN G,ZHANG X,HE W,et al.A scalable and reproducible preparation for the antitumor protein TLC,a human-derived telomerase inhibitor［J］.Protein Expr Purif,2021,187:105942.